ArticleFrontiers in immunology2024

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma.

Xiaodan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.